PP
RDY icon

Paloma Partners’s Dr. Reddy's Laboratories RDY Stock Holding History

Paloma Partners’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-29,585
Closed -$224K – 2435
2019
Q3 		$224K Buy
+29,585
New +$220K ﹤0.01% 1696

Other funds holding RDY

Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Aperio Group
Aperio Group Sausalito, California $33.8B AUM 31.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Parametric Portfolio Associates
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

Paloma Partners's RDY Position: Q4 2019 in Review

Paloma Partners sold out of Dr. Reddy's Laboratories (RDY) in Q4 2019, closing a stake of 29,585 shares — an estimated $224K sold.

Paloma Partners first reported a position in RDY in Q3 2019 and held it in 1 quarter. The position peaked at $224K in Q3 2019. 148 funds tracked by Wall St. Rank hold RDY as of Q4 2019.

  • Paloma Partners reported no remaining Dr. Reddy's Laboratories position as of Q4 2019 after selling out during the quarter.
  • Paloma Partners sold 29,585 Dr. Reddy's Laboratories shares in Q4 2019, an estimated $224K.
  • Paloma Partners first reported a position in Dr. Reddy's Laboratories in Q3 2019 and held it in 1 quarter.
  • Paloma Partners's Dr. Reddy's Laboratories position peaked at $224K in Q3 2019.
  • 148 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q4 2019.

Based on Paloma Partners's 13F filing for Q4 2019, filed 14 Feb 2020.